Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.740
+0.230 (15.23%)
At close: Sep 17, 2026, 4:00 PM EDT
1.760
+0.020 (1.15%)
Pre-market: Sep 18, 2026, 8:49 AM EDT

Bionano Genomics Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Bionano Genomics stock has a consensus rating of "Strong Buy" and an average price target of $5.00. The average 1-year stock price forecast is 187.36% higher than the current stock price, while the lowest is $4.00 (+129.89%) and the highest is $6.00 (+244.83%).

Price Target: $5.00 (+187.36%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$4.00$5.00$5.00$6.00
Change+129.89%+187.36%+187.36%+244.83%

Analyst Ratings

According to 1 stock analyst, the rating for Bionano Genomics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingNov '25Jan '26Mar '26Apr '26May '26Aug '26
Strong Buy111111
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Buy
Maintains
$4
BuyMaintains$4+129.89%Sep 11, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$7$6
BuyReiterates$7$6+244.83%Apr 13, 2026

Financial Forecast

Revenue This Year
32.14M
from 28.51M
Increased by 12.73%
Revenue Next Year
43.30M
from 32.14M
Increased by 34.74%
EPS This Year
-2.14
from -4.82
EPS Next Year
-0.97
from -2.14
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
17.98M27.80M36.12M30.78M28.51M32.14M
Revenue Growth
111.47%54.62%29.90%-14.79%-7.37%12.73%
Gross Profit
3.87M5.95M9.57M380.00K13.19M16.07M
Gross Margin
21.54%21.38%26.49%1.23%46.25%50.00%
Operating Income
-75.54M-129.58M-138.69M-87.17M-33.34M-28.70M
Net Income
-72.44M-132.60M-232.49M-112.02M-26.40M-29.31M
EPS
-----4.82-2.14
Free Cash Flow
-----4.58M201.52M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High32.5M
Avg32.1M
Low31.8M

Revenue Growth

Revenue Growth202620272028
High
13.9%
Avg
12.7%
Low
11.5%

EPS Forecast

EPS202620272028
High-2.14
Avg-2.14
Low-2.14

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-